CUSIP: 67552A108
Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,156,428
-
Share change
-
-187,896
-
Total reported value
-
$19,227,300
-
Price per share
-
$2.10
-
Number of holders
-
34
-
Value change
-
-$468,261
-
Number of buys
-
18
-
Number of sells
-
7
Quarterly Holders Quick Answers
What is CUSIP 67552A108?
CUSIP 67552A108 identifies OCRX - OCERA THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2017
-
Previous quarter:
Q3 2016
Recent filing periods for CUSIP 67552A108:
Institutional Holders of OCERA THERAPEUTICS INC - COM (OCRX) as of Q4 2016
As of 31 Dec 2016,
OCERA THERAPEUTICS INC - COM (OCRX) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,156,428 shares.
The largest 10 holders included
GREAT POINT PARTNERS LLC, INTERWEST VENTURE MANAGEMENT CO, VHCP Management II, LLC, VHCP Management, LLC, QVT Financial LP, DEERFIELD MANAGEMENT CO, SABBY MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, PURA VIDA INVESTMENTS, LLC, and Endurant Capital Management LP.
This page lists
34
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.